31st European Immunogenetics and Histocompatibility Conference and 25th Annual Meeting of the German Society for Immunogenetics
back to list
Dr. Emilia Jaskula
L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences/ Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry
Normal karyotype FLT3 ITD AML patients had lower number of gains identified by array CGH in the 17q21.31 region than those lacking the mutation.
Date: 31.05.2017 , Time: 18:00
Topic: Novel technologies